Results 241 to 250 of about 54,248 (321)

Correction: Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2. [PDF]

PLoS One
Xing Y, Niu T, Wang W, Li J, Li S, Janicki JS, Ruiz S, Meyer CJ, Wang XL, Tang D, Zhao Y, Cui T.   +11 more
europepmc   +1 more source

Invasive haemodynamic assessment in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Despite the increasing prevalence and substantial burden of heart failure with preserved ejection fraction (HFpEF), which constitutes up to 50% of all heart failure cases, significant challenges persist in its diagnostic and therapeutic strategies.
Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Husam M. Salah, Hidenori Yaku, Finn Gustafsson, Claudia Baratto, Sergio Caravita, Marat Fudim   +7 more
wiley   +1 more source

The Mechanical and Perfusion Basis of Exercise Limitation in Apical Hypertrophic Cardiomyopathy. [PDF]

JACC Adv
Hughes RK, Malcolmson J, Monteiro RP, Torlasco C, Davies R, Lopes LR, Mohiddin S, Captur G, Moon JC, Lloyd G.   +9 more
europepmc   +1 more source

The Diastolic Murmurs [PDF]

Indian Journal of Cardiovascular Disease in Women WINCARS, 2019
openaire   +1 more source

A Pilot Study Assessing Left Ventricle Diastolic Function in the Parasternal Long-axis View. [PDF]

West J Emerg Med
Murat Yazici M, Parça N, Hamdioğlu E, Kaçan M, Yavas I Ö, Bilir Ö.   +5 more
europepmc   +1 more source

Stress Distribution in the Canine Left Ventricle during Diastole and Systole

, 1970
Daniel D. Streeter, Ramesh N. Vaishnav, Dali J. Patel, Henry M. Spotnitz, John Ross, Edmund H. Sonnenblick   +5 more
openalex   +1 more source

Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements. [PDF]

Open Heart
Chang RS, Chiu IM, Tacon P, Abiragi M, Cao L, Hong G, Le J, Zou J, Daluwatte C, Ricchiuto P, Ouyang D.   +10 more
europepmc   +1 more source

Implementation of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa‐HF Registry)

ESC Heart Failure, EarlyView.
Abstract Aims The last released European guidelines on the management of heart failure (HF) recommend in patients with chronic HF with reduced ejection fraction (HFrEF) a pharmacological approach based on four fundamental drugs to be rapidly implemented and then uptitrated to modify disease progression.
Stefania Paolillo, Christian Basile, Federica Marzano, Dario Bruzzese, Piergiuseppe Agostoni, Irene Mattavelli, Angelo Aloisio, Pietro Ameri, Martina Solimano, Natale Daniele Brunetti, Paolo Calabrò, Arturo Cesaro, Matteo Cameli, Giulia Elena Mandoli, Erberto Carluccio, Chiara Belardinelli, Stefano Carugo, Laura Casalino, Emilia Chiuini, Deborah Cosmi, Frank Lloyd Dini, Mariafrancesca Di Santo, Gennaro Esposito, Ferdinando Ferrara, Maria Francesca Fierro, Gennaro Galasso, Luca Gallo, Antonella Rispoli, Paola Gargiulo, Francesco Grigioni, Andrea Segreti, Franco Guarnaccia, Natale Guarnaccia, Federico Guerra, Emanuele Cicchirillo, Ciro Indolfi, Mauro Larcher, Adele Lillo, Marco Metra, Roberta Montisci, Maria Francesca Marchetti, Savina Nodari, Francesco Fioretti, Ermanno Nardi, Ugo Oliviero, Alberto Palazzuoli, Giuseppe Patti, Marco Pepe, Filomena Pacelli, Fabrizio Perrone Filardi, Giuseppe Putortì, Giosuè Santoro, Michele Senni, Emilia D'Elia, Paolo Severino, Andrea D'Amato, Simona Soriano, Gianfranco Sinagra, Maddalena Rossi, Monica Franzese, Giovanni Smaldone, Giovanni Battista Zito, Pasquale Perrone Filardi   +62 more
wiley   +1 more source

Investigating Left Atrial Diameter and Heart Failure Onset in Middle-Aged and Elderly: A Retrospective-Prospective Study. [PDF]

Clin Cardiol
Wang A, Hu H, Zhang D, Qian G, Pan H, Zhai C, Yan Y.   +6 more
europepmc   +1 more source

Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices

ESC Heart Failure, EarlyView.
Abstract Aims No curative treatment is available for RASopathy‐associated childhood‐onset hypertrophic cardiomyopathy (RAS‐CM). Preclinical data and individual reports suggest a beneficial effect of small molecules targeting the RAS–mitogen‐activated protein (MAP) kinase (MAPK) pathway in severely affected RAS‐CM patients.
Jules Hamers, Payel Sen, Sarala Raj Murthi, Laura Papanakli, Maria von Stumm, Francesca Baessato, Julie Cleuziou, Christian Meierhofer, Peter Ewert, Andreas Dendorfer, Daphne Merkus, Cordula M. Wolf   +11 more
wiley   +1 more source